Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,623
datasets available to search
ShareScore release 0.7.1
Dataset results
10,623 results for “COVID”
Translated Emission Pathways (TEPs): Long-Term Simulations of COVID-19 CO2 Emissions and Thermosteric Sea Level Rise Projections - Supplementary Materials
<p>Supplementary materials for Gonzalez, A. R., & Lin, T. (2022). Translated Emission Pathways (TEPs): Long-Term Simulations of COVID-19 CO<sub>2</sub> Emissions and Thermosteric Sea Level Rise Projections. <em>Earth's Future</em>. In Press.</p> <p><strong>Summary: This study introduces climate science to a broader audience by presenting an accessible research framework and environmental data related to the ongoing COVID-19 pandemic. A series of translated emission pathways (TEPs) were constructed based on the CO<sub>2</sub> emission patterns from the various phases of COVID-19 response. In addition to resembling the forcing scenarios used within climate research, a thermosteric sea level rise analysis was incorporated to further emphasize the environmental benefits that can be obtained from long-term sustainability. As a promising start for including the general public in climate change discussion, this research promotes collective environmental action that mirrors the recommendations of the scientific community.</strong></p>
Life table data for "Bounce backs amid continued losses: Life expectancy changes since COVID-19"
<p><strong>Life table data for "Bounce backs amid continued losses: Life expectancy changes since COVID-19"</strong></p> <p><em>cc-by Jonas Schöley, José Manuel Aburto, Ilya Kashnitsky, Maxi S. Kniffka, Luyin Zhang, Hannaliis Jaadla, Jennifer B. Dowd, and Ridhi Kashyap. "Bounce backs amid continued losses: Life expectancy changes since COVID-19".</em></p> <p>These are CSV files of life tables over the years 2015 through 2021 across 29 countries analyzed in the paper "Bounce backs amid continued losses: Life expectancy changes since COVID-19".</p> <p><strong>40-lifetables.csv</strong></p> <p>Life table statistics 2015 through 2021 by sex, region and quarter with uncertainty quantiles based on Poisson replication of death counts. Actual life tables and expected life tables (under the assumption of pre-COVID mortality trend continuation) are provided.</p> <p><strong>30-lt_input.csv</strong></p> <p>Life table input data.</p> <ul> <li>`id`: unique row identifier</li> <li>`region_iso`: iso3166-2 region codes</li> <li>`sex`: Male, Female, Total</li> <li>`year`: iso year</li> <li>`age_start`: start of age group</li> <li>`age_width`: width of age group, Inf for age_start 100, otherwise 1</li> <li>`nweeks_year`: number of weeks in that year, 52 or 53</li> <li>`death_total`: number of deaths by any cause</li> <li>`population_py`: person-years of exposure (adjusted for leap-weeks and missing weeks in input data on all cause deaths)</li> <li>`death_total_nweeksmiss`: number of weeks in the raw input data with at least one missing death count for this region-sex-year stratum. missings are counted when the week is implicitly missing from the input data or if any NAs are encounted in this week or if age groups are implicitly missing for this week in the input data (e.g. 40-45, 50-55)</li> <li>`death_total_minnageraw`: the minimum number of age-groups in the raw input data within this region-sex-year stratum</li> <li>`death_total_maxnageraw`: the maximum number of age-groups in the raw input data within this region-sex-year stratum</li> <li>`death_total_minopenageraw`: the minimum age at the start of the open age group in the raw input data within this region-sex-year stratum</li> <li>`death_total_maxopenageraw`: the maximum age at the start of the open age group in the raw input data within this region-sex-year stratum</li> <li>`death_total_source`: source of the all-cause death data</li> <li> <p>`death_total_prop_q1`: observed proportion of deaths in first quarter of year</p> </li> <li> <p>`death_total_prop_q2`: observed proportion of deaths in second quarter of year</p> </li> <li> <p>`death_total_prop_q3`: observed proportion of deaths in third quarter of year</p> </li> <li> <p>`death_total_prop_q4`: observed proportion of deaths in fourth quarter of year</p> </li> <li> <p>`death_expected_prop_q1`: expected proportion of deaths in first quarter of year</p> </li> <li> <p>`death_expected_prop_q2`: expected proportion of deaths in second quarter of year</p> </li> <li> <p>`death_expected_prop_q3`: expected proportion of deaths in third quarter of year</p> </li> <li> <p>`death_expected_prop_q4`: expected proportion of deaths in fourth quarter of year</p> </li> <li>`population_midyear`: midyear population (July 1st)</li> <li>`population_source`: source of the population count/exposure data</li> <li>`death_covid`: number of deaths due to covid</li> <li>`death_covid_date`: number of deaths due to covid as of <date></li> <li>`death_covid_nageraw`: the number of age groups in the covid input data</li> <li>`ex_wpp_estimate`: life expectancy estimates from the World Population prospects for a five year period, merged at the midpoint year</li> <li>`ex_hmd_estimate`: life expectancy estimates from the Human Mortality Database</li> <li>`nmx_hmd_estimate`: death rate estimates from the Human Mortality Database</li> <li>`nmx_cntfc`: Lee-Carter death rate projections based on trend in the years 2015 through 2019</li> </ul> <p><em>Deaths</em></p> <ul> <li>source: <ul> <li>STMF input data series (https://www.mortality.org/Public/STMF/Outputs/stmf.csv)</li> <li>ONS for GB-EAW pre 2020</li> <li>CDC for US pre 2020</li> </ul> </li> <li>STMF: <ul> <li>harmonized to single ages via pclm</li> <li>pclm iterates over country, sex, year, and within-year age grouping pattern and converts irregular age groupings, which may vary by country, year and week into a regular age grouping of 0:110</li> <li>smoothing parameters estimated via BIC grid search seperately for every pclm iteration</li> <li>last age group set to [110,111)</li> <li>ages 100:110+ are then summed into 100+ to be consistent with mid-year population information</li> <li>deaths in unknown weeks are considered; deaths in unknown ages are not considered</li> </ul> </li> <li>ONS: <ul> <li>data already in single ages</li> <li>ages 100:105+ are summed into 100+ to be consistent with mid-year population information</li> <li>PCLM smoothing applied to for consistency reasons</li> </ul> </li> <li>CDC: <ul> <li>The CDC data comes in single ages 0:100 for the US. For 2020 we only have the STMF data in a much coarser age grouping, i.e. (0, 1, 5, 15, 25, 35, 45, 55, 65, 75, 85+). In order to calculate life-tables in a manner consistent with 2020, we summarise the pre 2020 US death counts into the 2020 age grouping and then apply the pclm ungrouping into single year ages, mirroring the approach to the 2020 data</li> </ul> </li> </ul> <p><em>Population</em></p> <ul> <li>source: <ul> <li>for years 2000 to 2019: World Population Prospects 2019 single year-age population estimates 1950-2019</li> <li>for year 2020: World Population Prospects 2019 single year-age population projections 2020-2100</li> </ul> </li> <li>mid-year population <ul> <li>mid-year population translated into exposures: <ul> <li>if a region reports annual deaths using the Gregorian calendar definition of a year (365 or 366 days long) set exposures equal to mid year population estimates</li> <li>if a region reports annual deaths using the iso-week-year definition of a year (364 or 371 days long), and if there is a leap-week in that year, set exposures equal to 371/364\*mid_year_population to account for the longer reporting period. in years without leap-weeks set exposures equal to mid year population estimates. further multiply by fraction of observed weeks on all weeks in a year.</li> </ul> </li> </ul> </li> </ul> <p><em>COVID deaths</em></p> <ul> <li>source: COVerAGE-DB (https://osf.io/mpwjq/)</li> <li>the data base reports cumulative numbers of COVID deaths over days of a year, we extract the most up to date yearly total</li> </ul> <p><em>External life expectancy estimates</em></p> <ul> <li>source: <ul> <li>World Population Prospects (https://population.un.org/wpp/Download/Files/1_Indicators%20(Standard)/CSV_FILES/WPP2019_Life_Table_Medium.csv), estimates for the five year period 2015-2019</li> <li>Human Mortality Database (https://mortality.org/), single year and age tables</li> </ul> </li> </ul>
Data for Figures and Tables in "Bounce backs amid continued losses: Life expectancy changes since COVID-19"
<p><strong>Data for Figures and Tables in "Bounce backs amid continued losses: Life expectancy changes since COVID-19"</strong></p> <p><em>cc-by Jonas Schöley, José Manuel Aburto, Ilya Kashnitsky, Maxi S. Kniffka, Luyin Zhang, Hannaliis Jaadla, Jennifer B. Dowd, and Ridhi Kashyap. "Bounce backs amid continued losses: Life expectancy changes since COVID-19".</em></p> <p>These are CSV files of data in the figures and tables published in the paper "Bounce backs amid continued losses: Life expectancy changes since COVID-19".</p> <p><strong>50-e0diffT.csv</strong></p> <p>Figure 1: Life expectancy changes 2019/20 and 2020/21 across countries. The countries are ordered by increasing cumulative life expectancy losses since 2019. Grey dots indicate the average annual LE changes over the years 2015 through 2019.</p> <p><strong>51-arriagaT.csv</strong></p> <p>Figure 2: Age contributions to life expectancy changes since 2019 separated for 2020 and 2021. The position of the arrowhead indicates the total contribution of mortality changes in a given age group to the change in life expectancy at birth since 2019. The discontinuity in the arrow indicates those contributions separately for the years 2020 and 2021. Annual contributions can compound or reverse. The total life expectancy change from 2019 to 2021 in a given country is the sum of the arrowhead positions across age.</p> <p><strong>52-sexdiff.csv</strong></p> <p>Figure 3: Change in the female life expectancy advantage from 2019 through 2021. Blue colors indicate an increase and red colors a decrease in the female life expectancy advantage. Muted colors indicate non-significant changes.</p> <p><strong>53-e0diffcodT.csv</strong></p> <p>Figure 4: Life expectancy deficit in 2021 decomposed into contributions by age and cause of death. LE deficit is defined as observed minus expected life expectancy had pre-pandemic mortality trends continued.</p> <p><strong>55-vaxe0.csv</strong></p> <p>Figure 5: Years of life expectancy deficit during October through December 2021 contributed by ages <60 and 60+ against % of population twice vaccinated by October 1st in the respective age groups. LE deficit is defined as the counterfactual LE from a Lee-Carter mortality forecast based on death rates for the fourth quarter of the years 2015 to 2019 minus observed LE.</p> <p><strong>54-tab_arriaga.csv</strong></p> <p>Table 1: Months of life expectancy (LE) changes and deficits (labelled ES) since the start of the pandemic attributed to age-specific mortality changes (labelled AT). LE deficit is defined as observed minus expected life expectancy had pre-pandemic mortality trends continued.</p>
Pollinator-flower interactions in gardens during the COVID-19 pandemic lockdown of 2020
<p>During the main COVID-19 pandemic lockdown period of 2020 an impromptu set of pollination ecologists came together via social media and personal contacts to carry out standardised surveys of the flower visits and plants in their gardens. The surveys involved 67 rural, suburban and urban gardens, of various sizes, ranging from 61.18<sup>o</sup> North in Norway to 37.96<sup>o</sup> South in Australia and resulted in a data set of 25,174 rows long and comprising almost 47,000 visits to flowers, as well as records of plants that were not visited by pollinators. In this first publication from the project we present a brief description of the data and make it freely available for any researchers to use in the future, the only restriction being that they cite this paper in the first instance. As well as producing a data set that we hope will be widely used in the future, the project helped enormously with the health and mental wellbeing of the participants, a by-product of ecological field work that cannot be over-estimated.</p>
BY-COVID Work Package 2 List of Resources
<p>Work Package 2: <em>Accessing heterogeneous data across domains and jurisdictions for enabling the downstream processing of COVID-19 and future pandemic episodes data </em>has gathered a relevant list of resources for the following areas: Non-patient related, Human-patient biomolecular, Human-patient clinical and health and socio-economics. </p>
Time series data of COVID-19 cases (rT-PCR-confirmed), hospitalisations (laboratory-confirmed), and hospital-associated deaths (laboratory confirmed) in South Africa, by imputed dates of symptom onset, from the start of the pandemic in March 2020 through April 2022.
<p>Time series data of COVID-19 cases (rT-PCR-confirmed), hospitalisations (laboratory-confirmed), and hospital-associated deaths (laboratory confirmed) in South Africa, by imputed dates of symptom onset, from the start of the pandemic in March 2020 through April 2022. These data were used to estimate the time-varying reproduction number (R) in South Africa, as described in https://www.medrxiv.org/content/10.1101/2022.07.22.22277932v1.full.</p>
Dysglycemias in patients admitted to ICUs with severe acute respiratory syndrome due to COVID-19 versus other causes – A cohort study - Dataset
<p>Dataset of a cohort whose summary is described below.</p> <p>Abstract</p> <p>Importance: Dysglycemias have been associated with worse prognosis in critically ill patients with or without diabetes, but data on their association with severe COVID-19 and outcomes are lacking. Objectives: To analyze the relationship of dysglycemias with COVID-19 in hospitalized patients with severe acute respiratory syndrome (SARS) and assess the influence of dysglycemias on mortality. Design, Setting and Participants: Cohort of consecutive patients with SARS and suspected COVID-19 hospitalized in intensive care units (ICUs) across eight hospitals in Curitiba-Brazil. Main Outcomes and Measures: The primary outcome was the influence of COVID-19 on the variation of the following parameters of dysglycemia: highest glucose level at admission, mean and highest glucose levels during ICU stay, mean glucose variation, and percentage of days with hyperglycemia. The secondary outcome was the influence of COVID-19 and each of the five parameters of dysglycemia on hospital mortality within 30 days from ICU admission. Results: We compared 703 patients with COVID-19 and 138 without COVID-19 admitted to the ICUs due to SARS. Compared with patients without COVID-19, those with COVID-19 had significantly higher glucose peaks at admission (198.1mg/dL vs. 167.8mg/dL, respectively) and during ICU stay (285.9mg/Dl vs. 230.9md/dL), higher mean daily glucose values (167.9mg/dL vs. 149.8mg/dL), higher percentage of days with hyperglycemia during ICU stay (vs. 45.0 vs. 31.5), and greater mean daily glucose variations (85.3mg/dL vs. 63.5mg/dL). However, these associations were lost after adjustment for APACHE II scores, SOFA scores, CRP level, corticosteroid use and nosocomial infection. Dysglycemia and COVID-19 were each independent risk factors for mortality. Conclusions and Relevance: Patients with SARS due to COVID-19 had higher mortality and more frequent dysglycemia than patients with SARS due to other causes. This association seemed to be related to disease severity and inflammation and was independent of corticosteroid use, suggesting no specific relationship with the SARS-CoV-2 infection.</p>
The SPIN covid19 RMRIO dataset: Global trade network data for the years 2016-2026 reflecting macroeconomic effects of the covid19 pandemic - B. Data for 2020 - 2026 - Covid scenario
<p>The SPIN covid19 RMRIO dataset is a time series of MRIO tables covering years from 2016-2026 on a yearly basis. The dataset covers 163 sectors in 155 countries.</p> <p>This repository includes data for years from 2020 to 2026 (<em>covid</em> scenario).<br> Code, method material and data for years 2016-2019 are stored in the following repository: <a href="http://doi.org/10.5281/zenodo.5713811">10.5281/zenodo.5713811</a><br> Data for the <em>counterfactual</em> scenario are stored in the following repository: <a href="https://doi.org/10.5281/zenodo.5713839">10.5281/zenodo.5713839</a></p> <p>Tables are generated using the <a href="https://github.com/TBeaufils/SPIN">SPIN method</a>, based on the <a href="https://doi.org/10.5281/ZENODO.3993659">RMRIO tables</a> for the year 2015, GDP, imports and exports data from the <a href="https://data.imf.org/?sk=4c514d48-b6ba-49ed-8ab9-52b0c1a0179b">International Financial Statistics</a> (IFS) and the World Economic Outlooks (WEO) of <a href="https://www.imf.org/en/Publications/WEO/weo-database/2019/October">October 2019</a> and <a href="https://www.imf.org/en/Publications/WEO/weo-database/2021/April">April 2021</a>.</p> <p>The <em>covid</em> scenario is in line with April 2021 WEO's data and includes the macroeconomic effects of Covid 19.</p> <p>All tables are labelled in 2015 US$ and valued in basic prices.</p>
Survey on the Effects of COVID-19 on the Wellbeing of Mexico City Households (ENCOVID- 19 CDMX – JULY 2020)
<p>Amid the COVID-19 outbreak, the ENCOVID-19 CDMX provides information on the well-being of Mexico City households in four main domains: labor, income, mental health, and food insecurity. It offers timely information to understand the social consequences of the pandemic and the lockdown measures. It is a cross-sectional telephone survey that, in addition to the four main domains and a set of COVID-19 related questions, includes key indicators to capture the impact of the pandemic on issues like education, social programs, and crime. This is the first dataset of the project, corresponding to July 2020, collected four months after the lockdown began in Mexico. Data collection was performed between the 8th and the 17th of July.</p>
Introducing the COVID-19 YouTube (COVYT) speech dataset featuring the same speakers with and without infection
<p>The COVYT dataset contains speech samples from individuals who self-reported their COVID-19 infection on public social media platforms (YouTube, Xiaohongshu). These videos, as well as accompanying videos of the same people prior to infection, were mined in an attempt to gather publicly-available data for COVID-19 research. This release includes the links to the original videos along with the accompanying manual segmentation and diarisation that identifies the utterances of the target individuals. We are additionally releasing features derived from the segmented utterances. Finally, the dataset includes partitioning information according to 4 different cross-validation schemes. See the arxiv pre-print for more details: https://arxiv.org/abs/2206.11045</p>
Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with severity in hospitalized COVID-19 patients
<p>Code and data for the manuscript "Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with severity in hospitalized COVID-19 patients".</p> <p>Contains all code located at <a href="https://github.com/lasalletj/COVID_Neutrophils">https://github.com/lasalletj/COVID_Neutrophils</a> as well as additional data files needed to run the code.</p> <p>Three additional publicly available data objects are required to run the code from start to finish. The first, covid.combined_final.Robj, from the Sinha et al. Nature Medicine 2022 paper (<a href="https://doi.org/10.1038/s41591-021-01576-3">https://doi.org/10.1038/s41591-021-01576-3</a>), is downloadable from the following link: <a href="https://figshare.com/ndownloader/files/31562957">https://figshare.com/ndownloader/files/31562957</a>. The other two required objects, seurat_COVID19_Neutrophils_cohort2_rhapsody_jonas_FG_2020-08-18.rds and seurat_COVID19_freshWB-PBMC_cohort2_rhapsody_jonas_FG_2020-08-18.rds, are from the Schulte-Schrepping et al. Cell 2020 paper (<a href="https://doi.org/10.1016/j.cell.2020.08.001">https://doi.org/10.1016/j.cell.2020.08.001</a>), and can be downloaded from <a href="https://beta.fastgenomics.org/datasets/detail-dataset-ee4b1a0f339140ad82f861aea35076f1#Files">https://beta.fastgenomics.org/datasets/detail-dataset-ee4b1a0f339140ad82f861aea35076f1#Files</a> and <a href="https://beta.fastgenomics.org/datasets/detail-dataset-1ad2967be372494a9fdba621610ad3f3#Files">https://beta.fastgenomics.org/datasets/detail-dataset-1ad2967be372494a9fdba621610ad3f3#Files</a>, respectively.</p> <p>Any additional information required to reanalyze the data reported in this work paper is available from the Lead Contact, Moshe Sade-Feldman (msade-feldman@mgh.harvard.edu) upon request.</p>
Monitoring feedback to authors on the quality of trials evaluating interventions aimed at preventing and treating COVID-19
<p>We aimed to assess transparency of reporting and risk of bias of randomized trials evaluating interventions aimed at preventing and treating COVID-19.</p> <p>This review is part of a larger project: the COVID-NMA project (Boutron 2020a). The COVID-NMA project aims to provide decision-makers with a complete, high-quality and up-to-date synthesis of evidence on interventions for the prevention and treatment of COVID 19. For this purpose, we perform a living mapping of all registered randomized controlled trials and a living evidence synthesis of data from RCTs. We developed a master protocol on the effect of all interventions for the prevention and treatment of COVID-19 (first published on April 8, 2020; an update on May 11, 2020, June 17, 2020, and September 8, 2020) (Boutron 2020b). We set-up a platform (<a href="https://covid-nma.com/">https://covid-nma.com</a>) where all our results are made available and updated weekly.</p>
Diagnostic accuracy of a set of clinical and radiological criteria for screening of COVID-19 using RT-PCR as the reference standard - Dataset
<p>Dataset of a cohort whose summary is described below.</p> <p>Abstract</p> <p><strong>Objective:</strong> To evaluate the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of a set of clinical-radiological criteria for COVID-19 screening in patients with severe acute respiratory failure (SARF) admitted to intensive care units (ICUs), using reverse-transcriptase polymerase chain reaction (RT-PCR) as the reference standard. <strong>Method: </strong>Diagnostic accuracy study including a historical cohort of 1009 patients consecutively admitted to ICUs across six hospitals in Curitiba (Brazil) from March to September, 2020. The sample was stratified into groups by the strength of suspicion for COVID-19 (strong <em>versus</em> weak) using parameters based on three clinical and radiological (chest computed tomography) criteria. The diagnosis of COVID-19 was confirmed by RT-PCR (referent). <strong>Results:</strong> With respect to RT-PCR, the proposed criteria had 98.5% (95% confidence interval [95% CI] 97.5–99.5%) sensitivity, 70% (95% CI 65.8–74.2%) specificity, 85.5% (95% CI 83.4–87.7%) accuracy, PPV of 79.7% (95% CI 76.6–82.7%) and NPV of 97.6% (95% CI 95.9–99.2%). <strong>Conclusion: </strong>The proposed set of clinical-radiological criteria were accurate in identifying patients with strong <em>versus</em> weak suspicion for COVID-19 and had high sensitivity and considerable specificity with respect to RT-PCR. These criteria may be useful for screening COVID-19 in patients presenting with SARF.</p>
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland – a multicentre cohort study
<p>For details, see publication</p>
Altered infective proficiency of the gut microbiome following COVID-19
<p><strong>The effects of SARS-CoV-2 infections comprise of many heterogeneous symptoms including several involving the human gastrointestinal tract. We assess the effects of COVID-19 on the host microbiome</strong></p>
Knowledge of Social Networks for Health is Associated with COVID-19 Health Protective Behaviors
<p>This is the dataset and stata code for the paper "Knowledge of Social Networks for Health is Associated with COVID-19 Health Protective Behaviors” submitted to Plos One May 1st, 2024.</p>
The UK COVID-19 Vocal Audio Dataset
<p>The UK COVID-19 Vocal Audio Dataset is designed for the training and evaluation of machine learning models that classify SARS-CoV-2 infection status or associated respiratory symptoms using vocal audio. The UK Health Security Agency recruited voluntary participants through the national Test and Trace programme and the REACT-1 survey in England from March 2021 to March 2022, during dominant transmission of the Alpha and Delta SARS-CoV-2 variants and some Omicron variant sublineages. Audio recordings of volitional coughs, exhalations, and speech (speech not available in open access version) were collected in the 'Speak up to help beat coronavirus' digital survey alongside demographic, self-reported symptom and respiratory condition data, and linked to SARS-CoV-2 test results. The UK COVID-19 Vocal Audio Dataset represents the largest collection of SARS-CoV-2 PCR-referenced audio recordings to date. PCR results were linked to 70,794 of 72,999 participants and 24,155 of 25,776 positive cases. Respiratory symptoms were reported by 45.62% of participants. This dataset has additional potential uses for bioacoustics research, with 11.30% participants reporting asthma, and 27.20% with linked influenza PCR test results.</p> <h3>Contents</h3> <ul> <li><strong>participant_metadata.csv</strong> row-wise, participant identifier indexed information on participant demographics and health status. Please see <a href="https://arxiv.org/pdf/2212.07738.pdf">A large-scale and PCR-referenced vocal audio dataset for COVID-19</a> for a full description of the dataset.</li> <li><strong>audio_metadata.csv</strong> row-wise, participant identifier indexed information on three recorded audio modalities, including audio filepaths. Please see <a href="https://arxiv.org/pdf/2212.07738.pdf">A large-scale and PCR-referenced vocal audio dataset for COVID-19</a> for a full description of the dataset.</li> <li><strong>train_test_splits.csv</strong> row-wise, participant identifier indexed information on train test splits for the following sets: 'Randomised' train and test set, Standard' train and test set, Matched' train and test sets, 'Longitudinal' test set and 'Matched Longitudinal' test set. Please see <a href="https://arxiv.org/abs/2212.08570">Audio-based AI classifiers show no evidence of improved COVID-19 screening over simple symptoms checkers</a> for a full description of the train test splits.</li> <li><strong>audio/ </strong>directory containing all the recordings in .wav format <ul> <li>Due to the large size of the dataset, to assist with ease of download, the audio files have been zipped into <strong>covid_data.z{ip, 01-24}.</strong> This enables the dataset to be downloaded in short periods, reducing the chances of a dropped internet connection scuppering progress. To unzip, first, ensure that all zip files are in the same directory. Then run the command 'unzip covid_data.zip' or right-click on 'covid_data.zip' and use a programme such as 'The Unarchiver' to open the file.</li> <li>Once extracted, to check the validity of the download, please run the 'python Turing-RSS-Health-Data-Lab-Biomedical-Acoustic-Markers/data-paper/unit-tests.py. All tests should pass with no exceptions. Please clone the GitHub repo detailed below.</li> </ul> </li> <li><strong>README.md</strong> full dataset descriptor.</li> <li><strong>DataDictionary_UKCOVID19VocalAudioDataset_OpenAccess.xlsx </strong>descriptor of each dataset attribute with the percentage coverage.</li> </ul> <h3>Code Base</h3> <p>The accompanying code can be found here: https://github.com/alan-turing-institute/Turing-RSS-Health-Data-Lab-Biomedical-Acoustic-Markers</p> <h3>Citations:</h3> <p>Please cite.</p> <p>@article{coppock2024audio,</p> <p> author = {Coppock, Harry and Nicholson, George and Kiskin, Ivan and Koutra, Vasiliki and Baker, Kieran and Budd, Jobie and Payne, Richard and Karoune, Emma and Hurley, David and Titcomb, Alexander and Egglestone, Sabrina and Cañadas, Ana Tendero and Butler, Lorraine and Jersakova, Radka and Mellor, Jonathon and Patel, Selina and Thornley, Tracey and Diggle, Peter and Richardson, Sylvia and Packham, Josef and Schuller, Björn W. and Pigoli, Davide and Gilmour, Steven and Roberts, Stephen and Holmes, Chris},</p> <p> title = {Audio-based AI classifiers show no evidence of improved COVID-19 screening over simple symptoms checkers},</p> <p> journal = {Nature Machine Intelligence},</p> <p> year = {2024},</p> <p> doi = {https://doi.org/10.1038/s42256-023-00773-8}</p> <p>}</p> <p>@article{budd2024,</p> <p> author={Jobie Budd and Kieran Baker and Emma Karoune and Harry Coppock and Selina Patel and Ana Tendero Cañadas and Alexander Titcomb and Richard Payne and David Hurley and Sabrina Egglestone and Lorraine Butler and George Nicholson and Ivan Kiskin and Vasiliki Koutra and Radka Jersakova and Peter Diggle and Sylvia Richardson and Bjoern Schuller and Steven Gilmour and Davide Pigoli and Stephen Roberts and Josef Packham Tracey Thornley Chris Holmes},</p> <p> title={A large-scale and PCR-referenced vocal audio dataset for COVID-19},</p> <p> journal={Scientific Data},</p> <p> year={2024},</p> <p> doi = {https://doi.org/10.1038/s41597-024-03492-w}</p> <p>}</p> <p>@article{Pigoli2022,</p> <p> author={Davide Pigoli and Kieran Baker and Jobie Budd and Lorraine Butler and Harry Coppock and Sabrina Egglestone and Steven G.\ Gilmour and Chris Holmes and David Hurley and Radka Jersakova and Ivan Kiskin and Vasiliki Koutra and George Nicholson and Joe Packham and Selina Patel and Richard Payne and Stephen J.\ Roberts and Bj\"{o}rn W.\ Schuller and Ana Tendero-Ca$\tilde{n}$adas and Tracey Thornley and Alexander Titcomb},</p> <p>title={Statistical Design and Analysis for Robust Machine Learning: A Case Study from Covid-19},</p> <p> year={2022},</p> <p> journal={arXiv},</p> <p> doi = {10.48550/ARXIV.2212.08571}</p> <p>}</p> <p> </p> <h3>The Dublin Core™ Metadata Initiative</h3> <p> </p> <p>- Title: The UK COVID-19 Vocal Audio Dataset, Open Access Edition.</p> <p>- Creator: The UK Health Security Agency (UKHSA) in collaboration with The Turing-RSS Health Data Lab.</p> <p>- Subject: COVID-19, Respiratory symptom, Other audio, Cough, Asthma, Influenza.</p> <p>- Description: The UK COVID-19 Vocal Audio Dataset Open Access Edition is designed for the training and evaluation of machine learning models that classify SARS-CoV-2 infection status or associated respiratory symptoms using vocal audio. The UK Health Security Agency recruited voluntary participants through the national Test and Trace programme and the REACT-1 survey in England from March 2021 to March 2022, during dominant transmission of the Alpha and Delta SARS-CoV-2 variants and some Omicron variant sublineages. Audio recordings of volitional coughs and exhalations were collected in the 'Speak up to help beat coronavirus' digital survey alongside demographic, self-reported symptom and respiratory condition data, and linked to SARS-CoV-2 test results. The UK COVID-19 Vocal Audio Dataset Open Access Edition represents the largest collection of SARS-CoV-2 PCR-referenced audio recordings to date. PCR results were linked to 70,794 of 72,999 participants and 24,155 of 25,776 positive cases. Respiratory symptoms were reported by 45.62% of participants. This dataset has additional potential uses for bioacoustics research, with 11.30% participants reporting asthma, and 27.20% with linked influenza PCR test results.</p> <p>- Publisher: The UK Health Security Agency (UKHSA).</p> <p>- Contributor: The UK Health Security Agency (UKHSA) and The Alan Turing Institute.</p> <p>- Date: 2021-03/2022-03</p> <p>- Type: Dataset</p> <p>- Format: Waveform Audio File Format audio/wave, Comma-separated values text/csv</p> <p>- Identifier: <strong>10.5281/zenodo.10043977</strong></p> <p>- Source: The UK COVID-19 Vocal Audio Dataset Protected Edition, accessed via application to <a href="https://www.gov.uk/government/publications/accessing-ukhsa-protected-data/accessing-ukhsa-protected-data">Accessing UKHSA protected data</a>.</p> <p>- Language: eng</p> <p>- Relation: The UK COVID-19 Vocal Audio Dataset Protected Edition, accessed via application to <a href="https://www.gov.uk/government/publications/accessing-ukhsa-protected-data/accessing-ukhsa-protected-data">Accessing UKHSA protected data</a>.</p> <p>- Coverage: United Kingdom, 2021-03/2022-03.</p> <p>- Rights: Open Government Licence version 3 (OGL v.3), © Crown Copyright UKHSA 2023.</p> <p>- accessRights: When you use this information under the Open Government Licence, you should include the following attribution: The UK COVID-19 Vocal Audio Dataset Open Access Edition, UK Health Security Agency, 2023, licensed under the <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/">Open Government Licence v3.0</a> and cite the papers detailed above.</p> <p> </p>
Datos diarios sobre la COVID-19 en Andalucía (España) a escala de provincia y municipio
<p>Data on daily COVID-19 confirmed cases, hospitalised people (both in conventional and intensive care units), and deaths, for Andalucía region in southern Spain, at the scale of both provinces and municipalities. Data cover the period from the very start of the pandemic (26 February 2020) up to 4 April 2022. The data were captured daily by <a href="https://frodriguezsanchez.net/" target="_blank" rel="noopener">Francisco Rodríguez-Sánchez</a> from the <a href="https://www.juntadeandalucia.es/institutodeestadisticaycartografia/salud/COVID19.html">official website </a>of Junta de Andalucía (wayback machine capture from 1 February 2022 <a href="https://web.archive.org/web/20220119092327/https://www.juntadeandalucia.es/institutodeestadisticaycartografia/badea/informe/anual?CodOper=b3_2314&idNode=42348" target="_blank" rel="noopener">here</a>). Note the official data were often changed retrospectively by the government as numbers were revised continuously. The full history of changes of both datasets can be checked at this GitHub repository: <a href="https://github.com/Pakillo/COVID19-Andalucia" target="_blank" rel="noopener">https://github.com/Pakillo/COVID19-Andalucia</a>. There you can also get the R code used to analyse those data, which were visualised in an online daily report here: <a href="https://pakillo.github.io/COVID19-Andalucia/evolucion-coronavirus-andalucia.html" target="_blank" rel="noopener">https://pakillo.github.io/COVID19-Andalucia/evolucion-coronavirus-andalucia.html</a>.</p> <p> </p>
COVID-19 Vaccines Database: 2020-2022
<p>The attached databases were generated and used in for the analysis of the research article <em>'Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models'. </em>They contain data related to COVID-19 vaccines' registration status, prices, production, purchases, deliveries, and investments between 2020 and 2022. <em><br></em></p> <p>These databases were compiled by collecting and revising data from two sources: UNICEF's COVID Market Dasboard, and the COVID-19 vaccine R&D investments tracker from the Geneva Graduate Institute's Global Health Centre: https://www.knowledgeportalia.org/covid-19-vaccine-r-d-funding.<em><br></em></p>
Effect of the Increased Nursing Attrition Rate on Nursing Administration Process during the Covid-19 Pandemic in a Selected Tertiary Care Hospital
<p><span>During<span> </span>the<span> </span>COVID-19<span> </span>outbreak,<span> </span>healthcare<span> </span>professionals,<span> </span>particularly<span> </span>nurses,<span> </span>were<span> </span>more<span> </span>prone to<span> </span>diseases.<span> </span>Globally<span> </span>attrition<span> </span>rate<span> </span>was<span> </span>high<span> </span>among<span> </span>nurses<span> </span>and<span> </span>during<span> </span>the<span> </span>pandemic,<span> </span>it<span> </span>increased because<span> </span>of<span> </span>various<span> </span>reasons<span> </span>such<span> </span>as<span> </span>the<span> </span>risk<span> </span>of<span> </span>infection,<span> </span>occupational<span> </span>and<span> </span>psychological<span> </span>stress, causing risk to their loved ones. This led to a chaotic situation where nurse managers were forced to implement specific strategic plans to deal with increased nurse attrition. This study aims<span> </span>to<span> </span>describe<span> </span>the<span> </span>impact<span> </span>of<span> </span>nurse<span> </span>attrition<span> </span>rate<span> </span>on<span> </span>nursing<span> </span>administration<span> </span>during<span> </span>COVID-19 at a selected tertiary care hospital. The research approach adopted in this study is descriptive cross-sectional. A total sample of 66 nurses involved in nursing administration. The data is collected through a structured questionnaire and the nurse attrition data during the COVID-19 pandemic period was collected from the interview method during the survey. Statistical tests used were frequency, percentage, mean, Standard Deviation (S.D). The study showed that there is a moderate impact of increased nurse attrition on nursing administration during the COVID-19 pandemic. The study led to the identification of gaps that need to be addressed in a similar crisis.</span></p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.